We are live on ! Find out more
PCA

Peddock Capital Advisors Portfolio holdings

AUM $501M
1-Year Est. Return 29.8%
This Fund
S&P 500
This Quarter Est. Return
+5.96%
1 Year Est. Return
+29.8%
3 Year Est. Return
+104.15%
5 Year Est. Return
+160.2%
10 Year Est. Return
+350.74%
AUM
$195M
AUM Growth
+$15.2M
Cap. Flow
+$5.76M
Cap. Flow %
2.95%
Top 10 Hldgs %
51.17%
Holding
249
New
137
Increased
22
Reduced
54
Closed
1

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$499K
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$490K
3
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$211K
4
WFC icon
Wells Fargo
WFC
+$205K
5
SHW icon
Sherwin-Williams
SHW
+$200K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$983K
2
IVW icon
iShares S&P 500 Growth ETF
IVW
+$237K
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$218K
4
PFE icon
Pfizer
PFE
+$150K
5
HPQ icon
HP
HPQ
+$146K

Sector Composition

Rank Sector Weight
1 Energy 32.45%
2 Technology 12.69%
3 Financials 8.54%
4 Healthcare 6.73%
5 Consumer Staples 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWO icon
226
iShares Russell 2000 Growth ETF
IWO
$14.1B
$7K ﹤0.01%
+31
New +$6.29K
SRPT icon
227
Sarepta Therapeutics
SRPT
$1.64B
$7K ﹤0.01%
+54
New +$5.45K
VWO icon
228
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$7K ﹤0.01%
+147
New +$6.23K
IWN icon
229
iShares Russell 2000 Value ETF
IWN
$14.3B
$6K ﹤0.01%
+47
New +$5.81K
ORC
230
Orchid Island Capital
ORC
$1.31B
$6K ﹤0.01%
+200
New +$5.73K
HSY icon
231
Hershey
HSY
$37.3B
$5K ﹤0.01%
+34
New +$5.04K
NFLX icon
232
Netflix
NFLX
$307B
$5K ﹤0.01%
+160
New +$4.74K
ALDX icon
233
Aldeyra Therapeutics
ALDX
$97.1M
$4K ﹤0.01%
+752
New +$4.34K
AMAT icon
234
Applied Materials
AMAT
$347B
$3K ﹤0.01%
+56
New +$3.15K
CGC
235
Canopy Growth
CGC
$376M
$3K ﹤0.01%
+12
New +$2.38K
FLR icon
236
Fluor
FLR
$6.54B
$3K ﹤0.01%
+175
New +$3.18K
IJS icon
237
iShares S&P Small-Cap 600 Value ETF
IJS
$8.12B
$3K ﹤0.01%
+32
New +$2.48K
ESTC icon
238
Elastic
ESTC
$6.7B
$2K ﹤0.01%
+30
New +$2.2K
EXPE icon
239
Expedia Group
EXPE
$36.5B
$2K ﹤0.01%
+21
New +$2.46K
NOK icon
240
Nokia
NOK
$46.9B
$2K ﹤0.01%
+409
New +$1.61K
YETI icon
241
Yeti Holdings
YETI
$3.87B
$2K ﹤0.01%
+66
New +$2.08K
RDS.A
242
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2K ﹤0.01%
+32
New +$1.87K
WORK
243
DELISTED
Slack Technologies, Inc.
WORK
$2K ﹤0.01%
+95
New +$2.12K
BMY.RT
244
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$2K ﹤0.01%
+666
New +$1.73K
ACB
245
Aurora Cannabis
ACB
$169M
$1K ﹤0.01%
+5
New +$1.86K
AMRC icon
246
Ameresco
AMRC
$980M
$1K ﹤0.01%
+69
New +$1.09K
PI icon
247
Impinj
PI
$4.24B
$1K ﹤0.01%
+31
New +$964
MNKD icon
248
MannKind Corp
MNKD
$1.19B
$0 ﹤0.01%
+200
New +$256
CELG
249
DELISTED
Celgene Corp
CELG
– –
-9,896
Closed -$983K
6 7 8 9
10

Similar funds

CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
HSG
Helen Stephens Group Fort Worth, Texas $501M AUM 16.23% 1-Year Est. Return
DAC
Dividend Assets Capital Ridgeland, South Carolina $501M AUM 13.71% 1-Year Est. Return
AA
Auxano Advisors Bellevue, Washington $501M AUM 24.15% 1-Year Est. Return
MCCP
Mission Creek Capital Partners San Francisco, California $501M AUM 28.4% 1-Year Est. Return
SWA
Serenus Wealth Advisors Santa Monica, California $501M AUM 10.41% 1-Year Est. Return
PRP
Peak Retirement Planning Columbus, Ohio $501M AUM 14.34% 1-Year Est. Return
MWP
MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return

Peddock Capital Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Peddock Capital Advisors held 249 positions worth $195M, up 8.4% from $180M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Peddock Capital Advisors's Q4 2019 filing shows 137 new, 22 increased, 54 reduced and 1 closed positions. Its largest new stake was Wells Fargo: 3,905 shares worth $210K. The largest sale was Celgene Corp, an estimated $983K.

By sector, the portfolio is most concentrated in Energy at 32% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Peddock Capital Advisors's largest Q4 2019 buy was Wells Fargo: 3,905 shares worth $210K.
  • Peddock Capital Advisors added most to Bristol-Myers Squibb in Q4 2019, an estimated $499K increase.
  • Peddock Capital Advisors's biggest Q4 2019 reduction was iShares S&P 500 Growth ETF, cutting an estimated $237K.
  • Peddock Capital Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $983K.
  • Peddock Capital Advisors's ten largest holdings make up 51% of its $195M portfolio in Q4 2019.
  • Peddock Capital Advisors opened 137 new positions and closed 1 in Q4 2019.
  • Peddock Capital Advisors's portfolio value rose 8.4% quarter-over-quarter to $195M.

Based on Peddock Capital Advisors's 13F filing for Q4 2019, filed 24 Jan 2020.